Integrin-Mediated Targeted Cancer Therapy Using c(RGDyK)-Based Conjugates of Gemcitabine-Reference-Cited by-同舟云学术

Integrin-Mediated Targeted Cancer Therapy Using c(RGDyK)-Based Conjugates of Gemcitabine

Published:2021-12-30 Issue:1 Volume:65 Page:271-284
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chatzisideri Theodora¹,Leonidis George¹,Karampelas Theodoros²,Skavatsou Eleni²,Velentza-Almpani Angeliki²,Bianchini Francesca³,Tamvakopoulos Constantin²^ORCID,Sarli Vasiliki¹^ORCID

Affiliation:

1. Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece

2. Center of Clinical Research, Experimental Surgery and Translational Research, Division of Pharmacology-Pharmacotechnology, Biomedical Research Foundation, Academy of Athens, Soranou Ephessiou Street 4, Athens GR-11527, Greece

3. Department of Experimental and Clinical Biomedical Sciences, University of Florence, V.le GB Morgagni 50, 50134 Firenze, Italy

Funder

European Regional Development Fund

European Social Fund

Government of Greece

Operational Programme "Competitiveness, Entrepreneurship and Innovation"

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c01468